Jubilant Pharma gets on the SLL road
Standard Chartered is the sole bookrunner and underwriter of the $400m loan
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
The content you are trying to view is exclusive to our subscribers.
To unlock this article: